A popular allergy medication was recalled across the country because of potential cross contamination with a heartburn medication that could lead to life-threatening side effects, according the U.S. Food and Drug Administration. Unique Pharmaceutical Laboratories recalled four lots of Cetirizine Hydrochloride, an antihistamine commonly sold over the counter as a generic version of Zyrtec. According to a release from the FDA, the medication may be cross contaminated with ranitidine, which is used to treat heartburn and acid indigestion. If someone with a “hypersensitivity” to the ingredients in ranitidine were to ingest a contaminated tablet, there is a “reasonable probability” of “serious adverse events including severe hypersensitivity reactions and anaphylaxis that manifests as hypotension, dyspnea, difficulty swallowing, throat and facial edema, generalized pruritic, urticaria, and loss of consciousness, which are all life-threatening,” the recall states. There have been no reports of adverse events related to the recall, according to the FDA. The recalled tablets were sold in bottles containing 100 5-mg tablets and shipped nationwide by New Jersey-based pharmaceutical company Rising Pharma Holdings Inc. to several retailers and wholesalers, according to the FDA. The companies discovered the issue after a pharmacy technician spotted red dots on the tablets while counting the allergy pills before dispensing them to a customer and filed a report. The product can be identified by reviewing the product name, manufacturer details and lot number displayed on the bottle. Products under the recall are all set to expire in October 2028 and have the following lot numbers: GY825029 GY825030 GY825031 GY825032 The products subject to the recall were distributed by Rising Pharma Holdings Inc. Anyone with questions is encouraged to call Rising Pharma Holdings at 1-844-874-7464. You can also email the company at [email protected]  or [email protected]. Patients are encouraged to reach out to their healthcare provider if they experience problems related to the potentially contaminated drugs.  ...read more read less